| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 迈瑞医疗 300760 | 医疗器械 | 26.2 | 23.9 | 1.71 | 5.08 | 2.5% | 65% | 64% | 18% | 0.0 | 4.4% | +3% | -24% | -10% | -30% | -45% | 28% | 2059 |
| 新产业 300832 | 医疗器械 | 23.6 | 21.8 | 1.28 | 4.51 | 2.3% | 56% | 71% | 18% | 0.0 | 4.1% | +14% | -20% | -6% | -13% | -43% | 34% | 405 |
| 鱼跃医疗 002223 | 医疗器械 | 23.0 | 16.7 | 1.04 | 1.94 | 4.6% | 44% | 50% | 11% | 0.0 | 5.4% | +4% | +7% | -31% | -29% | -45% | 30% | 259 |
| 心脉医疗 688016 | 医疗器械 | 18.8 | 16.9 | 1.21 | 2.52 | 2.6% | 77% | 75% | 17% | 0.0 | 2.7% | +15% | -15% | -4% | -26% | -26% | 32% | 107 |
| 欧普康视 300595 | 医疗器械 | 21.4 | 19.4 | 1.76 | 1.96 | 1.7% | 35% | 75% | 7% | 0.3 | 5.7% | +7% | -22% | -24% | -42% | -45% | 29% | 99 |
| 艾德生物 300685 | 医疗器械 | 19.8 | 16.2 | 1.01 | 3.53 | 2.6% | 47% | 84% | 8% | 0.4 | 4.9% | +12% | -9% | -14% | -30% | -36% | 37% | 67 |
| 普门科技 688389 | 医疗器械 | 33.8 | 22.2 | 1.01 | 2.31 | 2.5% | 36% | 63% | 22% | 1.2 | 4.0% | +2% | -11% | -12% | -21% | -34% | 26% | 48 |
| 安杰思 688581 | 医疗器械 | 19.3 | 17.0 | 1.13 | 1.62 | 2.0% | 38% | 71% | 8% | 0.3 | 3.6% | +17% | +0% | -11% | -38% | -38% | 32% | 41 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。